HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) saw a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the days-to-cover ratio is currently 0.1 days.
HAVN Life Sciences Price Performance
OTCMKTS HAVLF traded down $0.00 on Monday, reaching $0.05. The stock had a trading volume of 327 shares, compared to its average volume of 5,594. HAVN Life Sciences has a 12-month low of $0.05 and a 12-month high of $4.96. The business's 50-day moving average price is $0.07 and its 200 day moving average price is $0.59.
Get HAVN Life Sciences alerts:About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Recommended Stories
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- Three Small-Cap Biotech Stocks to Consider Now
- Two Blue Chip Health Companies The Institutions Are Buying
- What To Expect From The Q4 Earnings Reporting Season
- Here's What to Expect for the S&P 500 in 2023
- Can Bilibili be the Chinese Version of YouTube?
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.